HPV Vaccine: Protecting Men from Cancer

HPV vaccination isn’t just for girls and women — it also protects boys and men from several types of cancer, according to health experts in Indonesia.

The human papillomavirus (HPV) vaccine, long promoted primarily to prevent cervical cancer in females, offers significant protection for males as well, reducing their risk of anal, penile and oropharyngeal cancers caused by the virus.

Health officials emphasize that vaccinating boys helps break the chain of transmission, contributing to broader community immunity. When more people are vaccinated, the virus has fewer opportunities to spread, which benefits everyone regardless of gender.

In Indonesia, public health campaigns are increasingly highlighting the importance of including adolescent boys in routine HPV immunization programs. Experts note that early vaccination — ideally before exposure to the virus — provides the strongest defense.

The vaccine is most effective when given between the ages of 9 and 14, though it can still offer benefits for older teens and young adults who missed earlier doses. Health authorities recommend following national immunization schedules to ensure timely protection.

By extending HPV vaccination to males, countries like Indonesia aim to reduce the overall burden of HPV-related diseases and move closer to global cancer prevention goals. This inclusive approach supports both individual health and public health equity.